These tumours frequently exhibit poor infiltration of inflammatory cells and a low level of immunogenicity, characterised by low PD-L1 expression, reduced tumour mutational burden, a low level of infiltration of CD8+ tumour-infiltrating lymphocytes, and activation of the immunosuppressive CD73/adenosine axis [38,39]. This evidence concerns the gene NT5E and neoplasm.